Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis. Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization.
E M HuttenW Wh RoeloffzenA Ja LambeckT van den Born-BondtH Ng Oude ElberinkA A Jm van de VenPublished in: Journal of investigational allergology & clinical immunology (2024)